Gliclazide
Gliclazide
Gliclazide (pronounced gli-cla-zide) is an oral hypoglycemic (anti-diabetic drug) in the sulfonylurea class of medications. It is used to treat type 2 diabetes.
Etymology
The term "Gliclazide" is derived from its chemical name, N-(hexahydrocyclopenta[c]pyrrol-2(1H)-ylcarbamoyl)-4-methylbenzenesulfonamide.
Usage
Gliclazide is used to control blood sugar levels in people with type 2 diabetes. It works by causing the pancreas to release insulin, which helps to lower blood sugar.
Side Effects
Common side effects of Gliclazide include hypoglycemia, nausea, diarrhea, and skin rash. Severe side effects may include jaundice, thrombocytopenia, and anemia.
Related Terms
- Sulfonylurea: A class of oral hypoglycemic drugs to which Gliclazide belongs.
- Hypoglycemia: A condition that occurs when your blood sugar (glucose) level is too low.
- Type 2 diabetes: A chronic condition that affects the way the body processes blood sugar (glucose).
- Jaundice: A yellowing of the skin and eyes, which can be a side effect of Gliclazide.
- Thrombocytopenia: A condition characterized by abnormally low levels of platelets in the blood.
- Anemia: A condition marked by a deficiency of red cells or of hemoglobin in the blood.
External links
- Medical encyclopedia article on Gliclazide
- Wikipedia's article - Gliclazide
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski